Cargando…

Platelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-β1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-A/VEGF Receptor-1-Mediated Signaling †

The antifibrotic potential of platelet-rich plasma (PRP) is controversial. This study examined the effects of PRP on in vitro transforming growth factor (TGF)-β1-induced differentiation of fibroblasts into myofibroblasts, the main drivers of fibrosis, and the involvement of vascular endothelial grow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chellini, Flaminia, Tani, Alessia, Vallone, Larissa, Nosi, Daniele, Pavan, Paola, Bambi, Franco, Zecchi Orlandini, Sandra, Sassoli, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162453/ https://www.ncbi.nlm.nih.gov/pubmed/30235859 http://dx.doi.org/10.3390/cells7090142

Ejemplares similares

Platelet-Rich Plasma Modulates Gap Junction Functionality and Connexin 43 and 26 Expression During TGF-β1–Induced Fibroblast to Myofibroblast Transition: Clues for Counteracting Fibrosis
por: Squecco, Roberta, et al.
Publicado: (2020)

Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
por: Sassoli, Chiara, et al.
Publicado: (2013)

Influence of Platelet-Rich and Platelet-Poor Plasma on Endogenous Mechanisms of Skeletal Muscle Repair/Regeneration
por: Chellini, Flaminia, et al.
Publicado: (2019)

Red (635 nm), Near-Infrared (808 nm) and Violet-Blue (405 nm) Photobiomodulation Potentiality on Human Osteoblasts and Mesenchymal Stromal Cells: A Morphological and Molecular In Vitro Study
por: Tani, Alessia, et al.
Publicado: (2018)

Bone Marrow Mesenchymal Stromal Cells Stimulate Skeletal Myoblast Proliferation through the Paracrine Release of VEGF
por: Sassoli, Chiara, et al.
Publicado: (2012)

Sphingosine 1-Phosphate Receptor 1 Is Required for MMP-2 Function in Bone Marrow Mesenchymal Stromal Cells: Implications for Cytoskeleton Assembly and Proliferation
por: Sassoli, Chiara, et al.
Publicado: (2018)

Mesenchymal Stromal Cell Secreted Sphingosine 1-Phosphate (S1P) Exerts a Stimulatory Effect on Skeletal Myoblast Proliferation
por: Sassoli, Chiara, et al.
Publicado: (2014)

Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction
por: Squecco, Roberta, et al.
Publicado: (2021)

Morphological evidence for telocytes as stromal cells supporting satellite cell activation in eccentric contraction-induced skeletal muscle injury
por: Manetti, Mirko, et al.
Publicado: (2019)

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
por: McColl, Bradley K., et al.
Publicado: (2003)

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
por: Banks, R. E., et al.
Publicado: (1998)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Sphingosine 1-Phosphate (S1P)/ S1P Receptor Signaling and Mechanotransduction: Implications for Intrinsic Tissue Repair/Regeneration
por: Sassoli, Chiara, et al.
Publicado: (2019)

Correlation between Sialylation Status and Cell Susceptibility to Amyloid Toxicity
por: Sgambati, Eleonora, et al.
Publicado: (2022)

Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer
por: Kirwan, Cliona C, et al.
Publicado: (2009)

Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction
por: Sassoli, Chiara, et al.
Publicado: (2011)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF
por: Man, Xiao-Yong, et al.
Publicado: (2008)

An Increase in Vascular Endothelial Growth Factor (VEGF) and VEGF Soluble Receptor-1 (sFlt-1) Are Associated with Early Recurrent Spontaneous Abortion
por: Pang, Lihong, et al.
Publicado: (2013)

Mutual regulation between phosphofructokinase 1 platelet isoform and VEGF promotes glioblastoma tumor growth
por: Lim, Je Sun, et al.
Publicado: (2022)

Trophic Actions of Bone Marrow-Derived Mesenchymal Stromal Cells for Muscle Repair/Regeneration
por: Sassoli, Chiara, et al.
Publicado: (2012)

Expression of vascular endothelial growth factor (VEGF) in equine sarcoid
por: Martano, Manuela, et al.
Publicado: (2018)

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
por: Barratt, Shaney L., et al.
Publicado: (2018)

The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer
por: Goulart, André, et al.
Publicado: (2019)

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
por: Jha, Sawan Kumar, et al.
Publicado: (2017)

The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease
por: Holmes, David IR, et al.
Publicado: (2005)

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
por: Schmidinger, Manuela
Publicado: (2013)

Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy
por: Lin, Shuhua, et al.
Publicado: (2016)

Expression and correlation analysis of RegIV and vascular endothelial growth factors (VEGF-A and VEGF-C) in metastatic spinal tumors
por: Zhang, Shuquan, et al.
Publicado: (2017)

Short Communication: Interaction of Nerve Growth Factor (NGF) and Vascular Endothelial Growth Factor (VEGF) in Healthy Individuals
por: Groh, Adrian, et al.
Publicado: (2019)

Serum and molecular assessment of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1α (HIF-1α) in canine mammary tumors
por: Moschetta, Marina G, et al.
Publicado: (2013)

The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)
por: Jung, Susanne, et al.
Publicado: (2010)

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
por: Yamamoto, S., et al.
Publicado: (1997)

Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction
por: Jarvis, Ashley, et al.
Publicado: (2010)

Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value
por: Herrlinger, U, et al.
Publicado: (2004)

Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer
por: Kurebayashi, Junichi, et al.
Publicado: (1999)

Multiscale modeling of tumor response to vascular endothelial growth factor (VEGF) inhibitor
por: Hendrata, Melisa, et al.
Publicado: (2022)

Modeling the Cluster Size Distribution of Vascular Endothelial Growth Factor (VEGF) Receptors
por: Güven, Emine, et al.
Publicado: (2022)

Heparin-Induced Changes of Vascular Endothelial Growth Factor (VEGF(165)) Structure
por: Nemashkalova, Ekaterina L., et al.
Publicado: (2023)

Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?
por: Sánchez Ramírez, Javier, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7n5ask0agm44v58g06e8ocgk63